Actinium Pharmaceuticals Inc (ATNM)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.05B
EV to revenue ratio (TTM)
0.38
EV to ebitda
1.27
Financial Performance
Revenue (TTM)
$0.04B
Gross profit (TTM)
$0.04B
EBITDA
$0.01B
Profitability
Operating margin (TTM)
78.80%
Profit margin
32.20%
Return on assets (TTM)
11.60%
Return on equity (TTM)
45.90%
Per Share Metrics
Revenue per share (TTM)
$1.12
EPS
$0.36
Diluted EPS (TTM)
$0.36
Book value
$0.96
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
4.36
Trailing P/E
4.36
Forward P/E
8.50
PEG ratio
0
Price to sales ratio (TTM)
1.41
Price to book ratio (TTM)
1.60
Growth
Quarterly earnings growth (YoY)
-100.00%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
1
Buy
2
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.26